Saxenda (Liraglutide)
$190.00Saxenda (liraglutide 3.0 mg) is a daily GLP-1 receptor agonist injection that helps regulate appetite and caloric intake, assisting in significant, sustained weight loss alongside diet and exercise.
Why Choose Saxenda?
Daily flexibility allowing precise dose adjustments and smooth tolerance building for individuals preferring continuous daily control.
How to Use
Inject once daily at any time of day, with or without food. Start at 0.6 mg daily and increase weekly by 0.6 mg up to the 3.0 mg daily maintenance dose.
Safety Information
Do not combine with other GLP-1 receptor agonists or insulin without direct medical supervision. Monitor for signs of gallbladder issues.
Potential Side Effects
Mild nausea, diarrhea, constipation, low blood sugar (hypoglycemia), and headache may occur during initial weeks.
Product Facts
| Generic Name | Liraglutide |
| Brand Name | Saxenda |
| Type of Medication | GLP-1 Receptor Agonist (Daily) |
| FDA Approval Date | December 23, 2014 |
| Indications | Indicated as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management. |
| Dosage Forms | Prefilled multi-dose disposable pen (6 mg/mL, 3 mL solution) |
| Administration | Once daily subcutaneous injection |
| Special Precautions | Thyroid C-cell tumor warning. Monitor heart rate regularly during clinical follow-up. |
| Drug Interactions | Delays gastric emptying; evaluate potential interaction with narrow therapeutic window oral medications. |
| Use in Specific Populations | Contraindicated during pregnancy (Pregnancy Category X). Discontinue immediately if pregnancy occurs. |
| Prescription | Prescription Required |
| Manufacturer | Novo Nordisk |
How to Buy
Choose your preferred package option, complete checkout, and have your genuine Saxenda pens delivered safely to your door.